Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GSR | P00390 | 2/20 | 0.54 |
| ▸ | NOS2 | P35228 | 7/20 | 0.48 |
| ▸ | NOS1 | P29475 | 6/20 | 0.48 |
| ▸ | NOS3 | P29474 | 4/20 | 0.48 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.48 |
| ▸ | MEN1 | O00255 | 1/20 | 0.48 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.48 |
| ▸ | ARG2 | P78540 | 4/20 | 0.48 |
| ▸ | ARG1 | P05089 | 3/20 | 0.48 |
| ▸ | CYP1A2 | P05177 | 3/20 | 0.47 |
| ▸ | TSHR | P16473 | 2/20 | 0.47 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.47 |
| ▸ | GLA | P06280 | 1/20 | 0.47 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.47 |
| ▸ | APEX1 | P27695 | 1/20 | 0.47 |
| ▸ | SLC1A3 | P43003 | 2/20 | 0.47 |
| ▸ | SLC1A2 | P43004 | 2/20 | 0.47 |
| ▸ | SLC1A1 | P43005 | 2/20 | 0.47 |
| ▸ | SLC7A5 | Q01650 | 1/20 | 0.46 |
| ▸ | GRM8 | O00222 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1763743 | 1.00 | GSR (0.54) | GSRNOS2NOS1NOS3CYP2C19 | |
| SCHEMBL28159600 | 1.00 | GSR (0.54) | GSRNOS2NOS1NOS3CYP2C19 | |
| SCHEMBL28218940 | 0.86 | GGT1 (0.52) | GSRKMT2AARG2ARG1CYP1A2 | |
| SCHEMBL13269861 | 0.86 | GGT1 (0.52) | GSRKMT2AARG2ARG1CYP1A2 | |
| SCHEMBL31382811 | 0.85 | GSR (0.52) | GSRNOS2NOS1NOS3CYP2C19 | |
| SCHEMBL27886717 | 0.85 | GSR (0.52) | GSRNOS2NOS1NOS3CYP2C19 | |
| SCHEMBL29387596 | 0.83 | GSR (0.71) | GSRNOS2NOS1NOS3CYP2C19 | |
| SCHEMBL15987065 | 0.83 | GSR (0.71) | GSRNOS2NOS1NOS3CYP2C19 | |
| SCHEMBL17323357 | 0.83 | GSR (0.71) | GSRNOS2NOS1NOS3CYP2C19 | |
| SCHEMBL29291 | 0.83 | GSR (0.71) | GSRNOS2NOS1NOS3CYP2C19 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 19 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-5059653-A | Method for synthesizing a peptide containing a non-peptide bond | THE ADMINISTRATORS OF THE TULANE EDUCATIONAL FUND (US) | 1991-10-22 | — | — | US | claimed |
| EP-0257742-A2 | Method of synthesizing a peptide containing a non-peptide bond | The Administrators of The Tulane Educational Fund (US) | 1988-03-02 | — | — | EP | claimed |
| EP-3710482-A2 | COMPOSITIONS AND METHODS FOR MAKING AND USING BISPECIFIC ANTIBODIES | University Of Virginia Patent Foundation (US) | 2020-09-23 | — | — | EP | disclosed |
| EP-3672579-A2 | COMPOSITIONS AND METHODS FOR TREATING AGE-RELATED MACULAR DEGENERATION AND GEOGRAPHIC ATROPHY | University of Virginia Patent Foundation (US) | 2020-07-01 | — | — | EP | disclosed |
| WO-2019160907-A1 | REGULATING CD4+ T CELLS TO TREAT CLOSTRIDIUM DIFFICILE INFECTION | UNIVERSITY OF VIRGINIA PATENT FOUNDATION (US) | 2019-08-22 | — | — | WO | disclosed |
| WO-2017165367-A2 | COMPOSITIONS AND METHODS FOR REGULATING MYELINATION | UNIVERSITY OF VIRGINIA PATENT FOUNDATION (US) | 2017-09-28 | — | — | WO | disclosed |
| CN-107106655-A | Methods of treating diseases and disorders using interleukin-10 | 阿尔莫生物科技股份有限公司 | 2017-08-29 | — | — | CN | disclosed |
| CN-107001438-A | Interleukin-15 compositions and uses thereof | 阿尔莫生物科技股份有限公司 | 2017-08-01 | — | — | CN | disclosed |
| EP-2908848-A2 | COMPOSITIONS AND METHODS FOR REGULATING ARTERIAL TONE | Gaston, Benjamin M. (US) | 2015-08-26 | — | — | EP | disclosed |
| WO-2014066392-A2 | COMPOSITIONS AND METHODS FOR REGULATING ARTERIAL TONE | GASTON BENJAMIN M (US) | 2014-05-01 | — | — | WO | disclosed |
| EP-2601530-A2 | COMPOSITIONS AND METHODS FOR DETECTING, DIAGNOSING, AND TREATING CANCER | University Of Virginia Patent Foundation (US) | 2013-06-12 | — | — | EP | disclosed |
| WO-2012019184-A2 | COMPOSITIONS AND METHODS FOR DETECTING, DIAGNOSING, AND TREATING CANCER | UNIVERSITY OF VIRGINIA PATENT FOUNDATION (US) | 2012-02-09 | — | — | WO | disclosed |
| EP-1587944-A4 | KDR AND VEGF/KDR BINDING PEPTIDES AND THEIR USE IN DIAGNOSIS AND THERAPY | DYAX CORP (US) | 2007-03-21 | — | — | EP | disclosed |
| EP-1572724-A4 | KDR AND VEGF/KDR BINDING PEPTIDES AND THEIR USE IN DIAGNOSIS AND THERAPY | DYAX CORP (US) | 2007-03-14 | — | — | EP | disclosed |
| EP-1587944-A1 | KDR AND VEGF/KDR BINDING PEPTIDES AND THEIR USE IN DIAGNOSIS AND THERAPY | Dyax Corp. (US) | 2005-10-26 | — | — | EP | disclosed |
| EP-1572724-A2 | KDR AND VEGF/KDR BINDING PEPTIDES AND THEIR USE IN DIAGNOSIS AND THERAPY | Dyax Corp. (US) | 2005-09-14 | — | — | EP | disclosed |
| WO-2004065621-A1 | KDR AND VEGF/KDR BINDING PEPTIDES AND THEIR USE IN DIAGNOSIS AND THERAPY | DYAX CORP. (US) | 2004-08-05 | — | — | WO | disclosed |
| WO-2003074005-A2 | KDR AND VEGF/KDR BINDING PEPTIDES AND THEIR USE IN DIAGNOSIS AND THERAPY | DYAX CORP. (US) | 2003-09-12 | — | — | WO | disclosed |
| WO-1991019743-A2 | COMBINED TREATMENT WITH GnRH ANTAGONIST AND GnRH TO CONTROL GONADOTROPIN LEVELS IN MAMMALS | APPLIED RESEARCH SYSTEMS ARS HOLDING N.V. (AN) | 1991-12-26 | — | — | WO | disclosed |